133 related articles for article (PubMed ID: 8972687)
1. Methylcholanthrene-induced sarcomas in nude mice have short induction times and relatively low levels of surface MHC class I expression.
Engel AM; Svane IM; Mouritsen S; Rygaard J; Clausen J; Werdelin O
APMIS; 1996 Sep; 104(9):629-39. PubMed ID: 8972687
[TBL] [Abstract][Full Text] [Related]
2. Chemically induced sarcomas from nude mice are more immunogenic than similar sarcomas from congenic normal mice.
Svane IM; Engel AM; Nielsen MB; Ljunggren HG; Rygaard J; Werdelin O
Eur J Immunol; 1996 Aug; 26(8):1844-50. PubMed ID: 8765030
[TBL] [Abstract][Full Text] [Related]
3. Interferon-gamma-induced MHC class I expression and defects in Jak/Stat signalling in methylcholanthrene-induced sarcomas.
Svane IM; Engel AM; Nielsen M; Werdelin O
Scand J Immunol; 1997 Oct; 46(4):379-87. PubMed ID: 9350289
[TBL] [Abstract][Full Text] [Related]
4. Molecular aberrations in the MHC class I-restricted pathway for antigen presentation in methylcholanthrene sarcomas from nude mice: discrepancies between MHC mRNA and surface protein.
Engel AM; Svane IM; Madsen MW; Pedersen M; Werdelin O
Clin Exp Immunol; 1997 Aug; 109(2):323-31. PubMed ID: 9276529
[TBL] [Abstract][Full Text] [Related]
5. The susceptibility to cytotoxic T lymphocyte mediated lysis of chemically induced sarcomas from immunodeficient and normal mice.
Svane IM; Engel AM; Thomsen AR; Werdelin O
Scand J Immunol; 1997 Jan; 45(1):28-35. PubMed ID: 9010497
[TBL] [Abstract][Full Text] [Related]
6. CD8+ T cells are crucial for the ability of congenic normal mice to reject highly immunogenic sarcomas induced in nude mice with 3-methylcholanthrene.
Boesen M; Svane IM; Engel AM; Rygaard J; Thomsen AR; Werdelin O
Clin Exp Immunol; 2000 Aug; 121(2):210-5. PubMed ID: 10931133
[TBL] [Abstract][Full Text] [Related]
7. Immune selection in murine tumors. Ph.d thesis.
Svane IM; Engel AM
APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of MHC-class-I antigens in clones of methylcholanthrene-induced tumors. Implications for local growth and metastasis.
Algarra I; Gaforio JJ; Garrido A; Mialdea MJ; Pérez M; Garrido F
Int J Cancer Suppl; 1991; 6():73-81. PubMed ID: 2066185
[TBL] [Abstract][Full Text] [Related]
9. MCA sarcomas induced in scid mice are more immunogenic than MCA sarcomas induced in congenic, immunocompetent mice.
Engel AM; Svane IM; Rygaard J; Werdelin O
Scand J Immunol; 1997 May; 45(5):463-70. PubMed ID: 9160088
[TBL] [Abstract][Full Text] [Related]
10. H-2 antigens and tumour-associated transplantation antigens in clones derived from a methylcholanthrene-induced BALB/c tumour: their influence on the generation in vitro and in vivo of the specific anti-tumour immune response.
Pérez M; Garrido A; Algarra I; Caballero A; Delgado C; Collado MD; Fernández-Cruz E; Garrido F
Exp Clin Immunogenet; 1989; 6(3):204-18. PubMed ID: 2631798
[TBL] [Abstract][Full Text] [Related]
11. Serological analysis of BALB/C methylcholanthrene sarcoma Meth A by SEREX: identification of a cancer/testis antigen.
Ono T; Sato S; Kimura N; Tanaka M; Shibuya A; Old LJ; Nakayama E
Int J Cancer; 2000 Dec; 88(6):845-51. PubMed ID: 11093803
[TBL] [Abstract][Full Text] [Related]
12. Cells of chemically induced tumors differentially express major histocompatibility complex class I antigens.
Reagan WJ; Pardi D; Callahan GN
Cancer Invest; 1991; 9(3):269-78. PubMed ID: 1913230
[TBL] [Abstract][Full Text] [Related]
13. Interferon treatment of murine Meth-A sarcoma cells: effects on the malignant phenotype and expression of tumor-specific and H-2 antigens.
Wivel NA; Pitha PM
Int J Cancer; 1982 Nov; 30(5):649-54. PubMed ID: 6185444
[TBL] [Abstract][Full Text] [Related]
14. Alien histocompatibility determinants on the cell surface of sarcomas induced by methylcholanthrene. I. In vivo studies.
Parmiani G; Invernizzi G
Int J Cancer; 1975 Nov; 16(5):756-67. PubMed ID: 52628
[TBL] [Abstract][Full Text] [Related]
15. Tumors developing in nude mice express unusually large amounts of MHC class I antigens.
Petersen BL; Engel AM; Juul-Madsen H; Mouritsen S; Svane I; Werdelin O
APMIS; 1991 Dec; 99(12):1111-9. PubMed ID: 1772648
[TBL] [Abstract][Full Text] [Related]
16. Methylcholanthrene-induced mouse sarcomas express individually distinct major histocompatibility complex class I-associated peptides recognized by specific CD8+ T-cell lines.
Kono K; Petersson M; Ciupitu AM; Wen T; Klein G; Kiessling R
Cancer Res; 1995 Dec; 55(23):5648-55. PubMed ID: 7585649
[TBL] [Abstract][Full Text] [Related]
17. Measurement of H-2 antigen and immunogenicity of methylcholanthrene-induced murine sarcomas.
Pearson T; Sikora K; Lennox E
Br J Cancer; 1978 Apr; 37(4):530-5. PubMed ID: 77161
[TBL] [Abstract][Full Text] [Related]
18. Tumor development after 3-methylcholanthrene in immunologically deficient athymic-nude mice.
Stutman O
Science; 1974 Feb; 183(4124):534-6. PubMed ID: 4588620
[TBL] [Abstract][Full Text] [Related]
19. Changes in tumor-specific antigen expression during passage in vitro and in vivo of newly derived methylcholanthrene-induced sarcomas of BALB/C mice.
Law LW
Int J Cancer; 1980 Feb; 25(2):251-9. PubMed ID: 6156130
[TBL] [Abstract][Full Text] [Related]
20. Cell-mediated reactivity to antigens shared by Moloney-virus-induced lymphomas (LSTRA) and certain 3-methylcholanthrene-induced mouse sarcomas.
Hellström I; Hellström KE; Zeidman L; Bernstein ID; Brown JP
Int J Cancer; 1979 Apr; 23(4):555-64. PubMed ID: 86527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
